Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,577.68
(
-0.71%
)
US TECH 100
23,652.40
(
-0.60%
)
Dow Jones
45,857.91
(
-0.79%
)
Brent Oil
108.31
(
1.62%
)
Bitcoin
69,291.58
(
-2.74%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122798
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: oc631 post# 120563

Wednesday, 05/25/2011 6:29:17 PM

Wednesday, May 25, 2011 6:29:17 PM

Post# of 257259

ANDS has failed science and they are in business for the wrong reasons. Another short candidate.

I would have listed ANDS as one of my three shorts if its enterprise value were not so tiny.

A distant second [long] IMO would be BMY.

Not a pure enough HCV play to be mentioned in this context, IMO.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up